학술논문
'학술논문'
에서 검색결과 352건 | 목록
1~10
Academic Journal
S. Huhn; A. M. Poos; E. K. Mai; M. Hänel; H. J. Salwender; J. Dürig; I. W. Blau; C. Scheid; K. C. Weisel; M. Munder; O. Berlanga; U. Bertsch; H. Goldschmidt; N. Weinhold
HemaSphere, Vol 6, Pp 771-772 (2022)
Academic Journal
E. K. Mai; U. Bertsch; R. Fenk; D. Tichy; B. Besemer; J. Dürig; R. Schroers; I. von Metzler; M. Hänel; C. Mann; A. M. Asemissen; B. Heilmeier; E. Nievergall; S. Huhn; K. Kriegsmann; N. Weinhold; S. Luntz; T. A. W. Holderrried; K. Trautmann-Grill; D. Gezer; M. Klaiber-Hakimi; M. Müller; C. Khandanpour; W. Knauf; C. Scheid; M. Munder; T. Geer; H. Riesenberg; J. Thomalla; M. Hoffmann; M. S. Raab; H. J. Salwender; K. C. Weisel; H. Goldschmidt
HemaSphere, Vol 6, Pp 820-821 (2022)
Academic Journal
Mai EK; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany.; Goldschmid H; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany; National Centre for Tumour Diseases Heidelberg, Heidelberg, Germany. Electronic address: hartmut.goldschmidt@med.uni-heidelberg.de.; Miah K; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.; Bertsch U; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany; National Centre for Tumour Diseases Heidelberg, Heidelberg, Germany.; Besemer B; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.; Hänel M; Department of Internal Medicine III, Clinic Chemnitz, Chemnitz, Germany.; Krzykalla J; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.; Fenk R; Department of Haematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Schlenzka J; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany.; Munder M; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany.; Dürig J; Department for Haematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.; Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.; Huhn S; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany.; Hose D; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany.; Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.; Kunz C; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.; Mann C; Department of Haematology, Oncology and Immunology, Philipps-University Marburg, Marburg, Germany.; Weinhold N; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany.; Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.; Schroers R; Medical Clinic, University Hospital Bochum, Bochum, Germany.; von Metzler I; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany.; Schieferdecker A; Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Thomalla J; Haematology-Oncology Centre, Koblenz, Germany.; Reimer P; Clinic for Haematology, Oncology and Stem Cell Transplantation, Evangelische Kliniken Essen-Mitte, Essen, Germany.; Mahlberg R; Internal Medicine I, Hospital Mutterhaus der Borromäerinnen, Trier, Germany.; Graeven U; Medical Clinic I, Hospital Maria Hilf, Mönchengladbach, Germany.; Kremers S; Haematology-Oncology Centre, Lebach, Germany.; Martens UM; Haematology, Oncology, Palliative Care, SLK Clinic Heilbronn, Heilbronn, Germany.; Kunz C; Haematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany.; Hensel M; Mannheimer Onkologie Praxis, Mannheim, Germany.; Benner A; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.; Seidel-Glätzer A; Coordination Centre for Clinical Trials Heidelberg, Heidelberg, Germany.; Weisel KC; Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Raab MS; Department of Medicine V, Heidelberg Myeloma Centre, University Hospital Heidelberg, Heidelberg, Germany.; Salwender HJ; Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona and St Georg, Hamburg, Germany.
Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Academic Journal
Hummel M; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany.; Hielscher T; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany.; Emde-Rajaratnam M; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and St Georg, Hamburg, Germany.; Beck S; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Universitätsklinikum Heidelberg, Molekularpathologisches Zentrum, Heidelberg, Germany.; Scheid C; Department I of Internal Medicine, University of Cologne, Cologne, Germany.; Bertsch U; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Goldschmidt H; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.; Jauch A; Universität Heidelberg, Institut für Humangenetik, Heidelberg, Germany.; Moreaux J; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France.; Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Hose D; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Kriegsmann K; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Laborarztpraxis Rhein-Main MVZ GbR, Frankfurt am Main, Germany.; Ton GNHQ; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Awwad MHS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.; Bertsch U; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.; Besemer B; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.; Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.; Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Munder M; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany.; Dürig J; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.; Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.; Huhn S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Hose D; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.; Mann C; Department of Hematology, Oncology and Immunology, Phillips-University Marburg, Marburg, Germany.; Weinhold N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.; Schroers R; Department of Hematology, Oncology, Ruhr-University Bochum, Bochum, Germany.; von Metzler I; Department of Internal Medicine II, University Hospital Frankfurt a.M., Frankfurt a.M., Germany.; Schieferdecker A; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Thomalla J; Hematology/Oncology Center, Koblenz, Germany.; Reimer P; Evang. Kliniken Essen-Mitte, Evang. Krankenhaus Essen-Werden, Essen, Germany.; Mahlberg R; Internal Medicine I, Hospital Mutterhaus der Borromäerinnen, Trier, Germany.; Graeven U; Department of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany.; Kremers S; Hematology/Oncology Center, Lebach, Germany.; Martens UM; Hematology, Oncology, Palliative Care, SLK Clinics Heilbronn, Heilbronn, Germany.; Kunz C; Hematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany.; Hensel M; Mannheimer Onkologie Praxis, Mannheim, Germany.; Seidel-Glätzer A; Coordination Centre for Clinical Trials (KKS) Heidelberg, Heidelberg, Germany.; Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Salwender HJ; Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona and St. Georg, Hamburg, Germany.; Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Goldschmidt H; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.; Mai EK; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Hundemer M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. michael.hundemer@med.uni-heidelberg.de.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium.; Independent Myeloma Alliance, 8808 Pfäffikon, SZ, Switzerland.; Salwender H; Department of Internal Medicine II, Asklepios Klinik Altona, 22763 Hamburg, Germany.; Martin H; Department of Medicine, Hematology/Oncology, Goethe-University of Frankfurt, 60590 Frankfurt, Germany.; Scheid C; Department I of Internal Medicine, University of Cologne, 50923 Köln, Germany.; Hielscher T; Abteilung für Biostatistik, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.; Bertsch U; Medizinische Klinik V, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany.; Hummel M; Abteilung für Biostatistik, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.; Jauch A; Institut für Humangenetik, Universität Heidelberg, 69120 Heidelberg, Germany.; Knauf W; Onkologische Gemeinschaftspraxis, Agaplesion Bethanien Krankenhaus, 60389 Frankfurt, Germany.; Emde-Rajaratnam M; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium.; Beck S; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium.; Neben K; Klinikum Mittelbaden, Medizinische Klinik 2, 76530 Baden-Baden, Germany.; Dührig J; Katholisches Krankenhaus Hagen, 58099 Hagen, Germany.; Lindemann W; Department of Hematology, University Hospital Essen, 45147 Essen, Germany.; Schmidt-Wolf IGH; Department of Integrated Oncology, CIO Bonn, University of Bonn, 53127 Bonn, Germany.; Hänel M; Department of Internal Medicine III, Klinikum Chemnitz GmbH, 09113 Chemnitz, Germany.; Blau IW; Medical Clinic III Hematology and Oncology, Charité University Medicine Berlin, 13353 Berlin, Germany.; Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; Weinhold N; Medizinische Klinik V, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany.; Raab MS; Medizinische Klinik V, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany.; Goldschmidt H; Medizinische Klinik V, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, 69120 Heidelberg, Germany.; Choon-Quinones M; Independent Myeloma Alliance, 8808 Pfäffikon, SZ, Switzerland.; Hose D; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), 1090 Jette, Belgium.; Independent Myeloma Alliance, 8808 Pfäffikon, SZ, Switzerland.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Electronic Resource
Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J.; Zweegman, Sonja; Raab, Marc S.; Munder, Markus; Pantani, Lucia; Mancuso, Katia; Brossart, Peter; Beksac, Meral; Blau, Igor W.; Dürig, Jan; Besemer, Britta; Fenk, Roland; Reimer, Peter; van der Holt, Bronno; Hänel, Mathias; von Metzler, Ivana; Graeven, Ullrich; Müller-Tidow, Carsten; Boccadoro, Mario; Scheid, Christof; Dimopoulos, Meletios A.; Hillengass, Jens; Weisel, Katja C.; Cavo, Michele; Sonneveld, Pieter; Goldschmidt, Hartmut
Mai , E K , Hielscher , T , Bertsch , U , Salwender , H J , Zweegman , S , Raab , M S , Munder , M , Pantani , L , Mancuso , K , Brossart , P , Beksac , M , Blau , I W , Dürig , J , Besemer , B , Fenk , R , Reimer , P , van der Holt , B , Hänel , M , von Metzler , I , Graeven , U , Müller-Tidow , C , Boccadoro , M , Scheid , C , Dimopoulos , M A , Hillengass , J , Weisel , K C , Cavo , M , Sonneveld , P & Goldschmidt , H 2024 , ' Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients ' , Leukemia , vol. 38 , no. 3 , pp. 640-647 .
Academic Journal
Mai EK; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.; Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bertsch U; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Salwender HJ; Tumorzentrum Asklepios Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.; Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.; Raab MS; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Munder M; Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany.; Pantani L; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Azienda Ospedaliero-Universitaria di Bologna, Università di Bologna, Bologna, Italy.; Mancuso K; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Azienda Ospedaliero-Universitaria di Bologna, Università di Bologna, Bologna, Italy.; Brossart P; Department of Internal Medicine III, University Hospital Bonn, Bonn, Germany.; Beksac M; Department of Hematology, Ankara University School of Medicine, Ankara, Turkey.; Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.; Dürig J; Department of Hematology, University Clinic Essen, Essen, Germany.; Besemer B; Department of Hematology, Oncology and Immunology, University Hospital Tübingen, Tübingen, Germany.; Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Reimer P; Klinik für Hämatologie, Evangelische Kliniken Essen Mitte, Evangelisches Krankenhaus Essen-Werden, Essen, Germany.; van der Holt B; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.; von Metzler I; Medical Clinic II, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.; Graeven U; Department of Internal Medicine I, Hospital Maria Hilf GmbH, Mönchengladbach, Germany.; Müller-Tidow C; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Boccadoro M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.; Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.; Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Hillengass J; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Azienda Ospedaliero-Universitaria di Bologna, Università di Bologna, Bologna, Italy.; Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Goldschmidt H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Goldschmidt H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany. Electronic address: hartmut.goldschmidt@med.uni-heidelberg.de.; Mai EK; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Bertsch U; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.; Fenk R; Department of Hematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Nievergall E; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Tichy D; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.; Besemer B; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.; Dürig J; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.; Schroers R; Medical Clinical, University Hospital Bochum, Bochum, Germany.; von Metzler I; Department of Medicine, Hematology, and Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.; Hänel M; Department of Internal Medicine III, Clinic Chemnitz, Chemnitz, Germany.; Mann C; Department for Hematology, Oncology, and Immunology, University Hospital of Gießen and Marburg, Marburg, Germany.; Asemissen AM; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Heilmeier B; Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany.; Weinhold N; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Huhn S; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Kriegsmann K; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Luntz SP; Coordination Centre for Clinical Trials Heidelberg, Heidelberg, Germany.; Holderried TAW; Department of Oncology, Hematology, ImmunoOncology, and Rheumatology, University Hospital Bonn, Bonn, Germany.; Trautmann-Grill K; Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany.; Gezer D; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.; Klaiber-Hakimi M; Clinic for Hematology, Oncology and Palliative Care, Marien Hospital Düsseldorf, Düsseldorf, Germany.; Müller M; Clinic for Hematology, Oncology and Immunology, Klinikum Siloah Hannover, Hannover, Germany.; Khandanpour C; Medical Clinic A, University Hospital Münster, Münster, Germany.; Knauf W; Center for Hematology and Oncology Bethanien, Frankfurt, Germany.; Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.; Munder M; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany.; Geer T; Department of Internal Medicine III, Diakoneo Clinic Schwäbisch-Hall, Schwäbisch-Hall, Germany.; Riesenberg H; Hematology and Oncology Center, Bielefeld, Germany.; Thomalla J; Hematology and Oncology Center, Koblenz, Germany.; Hoffmann M; Medical Clinic A, Clinic Ludwigshafen, Ludwigshafen, Germany.; Raab MS; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona, AK St Georg, Hamburg, Germany.; Weisel KC; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Academic Journal
Emde-Rajaratnam M; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Beck S; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Universitätsklinikum Heidelberg, Molekularpathologisches Zentrum, Heidelberg, Germany.; Benes V; Europäisches Laboratorium für Molekularbiologie, GeneCore, Heidelberg, Germany.; Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and St. Georg, Hamburg, Germany.; Bertsch U; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Scheid C; Department I of Internal Medicine, University of Cologne, Cologne, Germany.; Hänel M; Department of Internal Medicine III, Klinikum Chemnitz GmbH, Chemnitz, Germany.; Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hielscher T; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany.; Raab MS; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Goldschmidt H; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.; Jauch A; Universität Heidelberg, Institut für Humangenetik, Heidelberg, Germany.; Maes K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; De Bruyne E; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Menu E; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; De Veirman K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Moreaux J; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France.; Vanderkerken K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Hose D; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] H. J. Salwender
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어